A study reported that AZD4547 significantly retarded tumor growth by inducing the mesenchymal–epithelial transition (EMT), reducing ESCC stem cell-like cell populations (CSCs), and inhibiting FGF2-mediated FGFR/ERK signaling [29]. Here, FGF2 is linked to neoplasm.